Irbesartan and Hydrochlorothiazide

Product NDC
29300-215
11-digit product format
293000215
Labeler code
29300
Product ID
29300-215_a2e7c9d1-50c4-4a14-8dd5-8dfc6d63a29a
Type
HUMAN PRESCRIPTION DRUG
Nonproprietary name
Irbesartan and Hydrochlorothiazide
Dosage form
TABLET, FILM COATED
Route
ORAL
Labeler
Unichem Pharmaceuticals (USA), Inc.
Application
ANDA207018
Marketing category
ANDA
Marketing start
2017-09-19
Substance
HYDROCHLOROTHIAZIDE; IRBESARTAN
Active strength
12.5; 150 mg/1; mg/1
Pharmacologic classes
Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC], Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]
NDC exclude flag
No
Listing certified through
2026-12-31
Current FDA listing
Yes

Additional Listing Data#

Finished product
Yes
Brand name base
Irbesartan and Hydrochlorothiazide
Listing expiration
2026-12-31

Active Ingredients#

Ingredient, Strength table
IngredientStrength
HYDROCHLOROTHIAZIDE12.5 mg/1
IRBESARTAN150 mg/1

Harmonized Identifiers#

Field, Values table
FieldValues
Unii0J48LPH2TH, J0E2756Z7N
Rxcui310792, 310793

DailyMed Product Concepts#

Product concept, Relation, Version table
Product conceptRelationVersionEffective
c19ec24d-2c40-4b8d-7c20-500ffa3660a1Product name320260303
1199f4b7-b537-466c-9a1c-cb09131e9f8bProduct name120251117
e1a63b6e-1877-c2c1-01a3-03ea2817aa6fProduct name320251027
b15e9aa6-d523-ca97-480e-570e0543a342Product name420251024
96816964-c075-ffa7-b7b8-d8570411a3b9Product name720250305
362d7abb-94e6-4c60-9a58-266894157713Product name120231023
594e2c86-3079-4e6e-96c9-48f7a8afc78dProduct name120230718
162cbc9d-ecc3-72ba-af9f-c76e2756ef54Product name320221207
9b303cd4-3186-2454-5706-3137e8b2dfd2Product name420221110
a62a50ac-1535-4461-9768-8ae703e2e9fbProduct name120210525
47fc2fe9-7afb-4be9-989d-787aaa6ad0eaProduct name120200505
a8e65197-7914-7acf-c7ec-914d53819b34Product name320190624
8b67f333-47d1-8464-7ce4-406d3dbb295fProduct name720190618
89a57420-ab44-5323-14f9-595159145f9bProduct name220190612
c27b049d-3258-48cf-ebe5-08c236ae78e2Product name320190610
816b97af-edc5-4060-aff1-b814bdbcad50Product name120190415
34942a29-de4f-d63c-7755-ba18fe1411a0Product name620180619
00fc2cf9-672f-3e0b-6afa-43cbc864d058Product name420180613
15b375b1-89c7-9594-80df-5a8c8864aee0Product name320180108
a7349398-661d-d9fc-46df-7e128bbd61d9Product name520171113
1bdb87cf-9b1f-6a51-5eb7-d182aaffaa3dProduct name220170719
419aab54-5d5a-4146-9453-026d4a9991beProduct name220170525
e0eeb018-194e-4b70-a57d-bac47a97b8eaProduct name120160825
55bffd21-17e1-ff02-2e8f-1f9a532b9502Product name220150320
89dac932-b90a-4410-9ab1-84c53e57de25Product name120150316
ea069444-e874-4c28-833f-d2f52734ef4dProduct name120150206
041df61b-f8b6-48a6-7b67-411e1412678bProduct name120140508
0ad8bdca-888e-00da-648b-6a4de854a167Product name120140508
433a3439-b8f3-d13a-d2c8-9b221d628d60Product name120140508
59212689-39e5-a976-6d21-882d76d8079aProduct name120140508
7613b1a5-acb6-4e5e-6048-c44deeeb1212Product name120140508
78637fb0-95c8-441f-e4b4-db1274b6f956Product name120140508
9514609b-a2a9-f8ec-6ba6-3f8e5ee89877Product name120140508
bc07ef78-e82d-0c19-31f4-31f263780582Product name120140508
d723478e-ad4a-ec23-6bd7-cfe33e1e3840Product name120140508
df89bd47-2db4-d593-ab37-d11953fd5536Product name120140508
f151007d-265d-9fbe-857d-1d44f1cb76baProduct name120140508

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDCProductDescriptionFormQuantityStrengthSPL version
29300-215-10Irbesartan and Hydrochlorothiazide1000 in 1 BOTTLE, PLASTICTABLET, FILM COATED100012
29300-215-13Irbesartan and Hydrochlorothiazide30 in 1 BOTTLE, PLASTICTABLET, FILM COATED3012
29300-215-19Irbesartan and Hydrochlorothiazide90 in 1 BOTTLE, PLASTICTABLET, FILM COATED9012

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDCDashboard titleSPL versionValidationDashboard ZIP
29300-215IRBESARTAN AND HYDROCHLOROTHIAZIDE TABLET, FILM COATED [UNICHEM PHARMACEUTICALS (USA), INC.]10Current NDC, Legacy NDC, 3 package rows20221217_181324c5-256f-4570-a0bb-8bc908deb2e2.zip

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUIRxNorm stringTTYDailyMedSPL version
310792irbesartan 150 MG / hydroCHLOROthiazide 12.5 MG Oral TabletPSN181324c5-256f-4570-a0bb-8bc908deb2e212
310793irbesartan 300 MG / hydroCHLOROthiazide 12.5 MG Oral TabletPSN181324c5-256f-4570-a0bb-8bc908deb2e212
310792hydrochlorothiazide 12.5 MG / irbesartan 150 MG Oral TabletSCD181324c5-256f-4570-a0bb-8bc908deb2e212
310793hydrochlorothiazide 12.5 MG / irbesartan 300 MG Oral TabletSCD181324c5-256f-4570-a0bb-8bc908deb2e212
310792HCTZ 12.5 MG / irbesartan 150 MG Oral TabletSY181324c5-256f-4570-a0bb-8bc908deb2e212
310793HCTZ 12.5 MG / irbesartan 300 MG Oral TabletSY181324c5-256f-4570-a0bb-8bc908deb2e212

Packages#

Package NDC, 11-digit format, Description table
Package NDC11-digit formatDescriptionMarketing startMarketing endSampleExclude flagStatus
29300-215-10293000215101000 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (29300-215-10) 2018-03-310000-00-00NoNoCurrent
29300-215-132930002151330 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (29300-215-13) 2018-03-310000-00-00NoNoCurrent
29300-215-192930002151990 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (29300-215-19) 2018-03-310000-00-00NoNoCurrent